Recent Blog Posts

View Post: IDARUBICIN MAYBE BETTER FOR AML
23 Oct 2009 by Dr. NICK  
PATIENTS AND METHODS: We randomly assigned 2157 patients (age range, 15 to 60 years) to receive intensive induction-consolidation chemotherapy containing either daunorubicin, idarubicin, or mitoxantrone. ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/

---

View Post: high efficacy and low toxicity of apl induction with concurrent ...
6 Sep 2009 by Gulfoncology  
... previously untreated apl patients in a pilot treatment program consisting of concurrent induction using idarubicin/atra followed by an exclusive outpatient post-remission therapy using single dose of idarubicin and intermittent atra ...
View Blog: Araboncology - http://www.gulfoncology.org/blog/blog.html

---

View Post: fda approves app pharmaceuticals' idarubicin hci injection
10 Aug 2009 by admin  
app pharmaceuticals, inc., a wholly owned subsidiary of fresenius kabi pharmaceuticals holding, inc. (nasdaq:apcvz), announced today that it has received approval from the us food and drug administration (fda) to market idarubicin ...
View Blog: Medical News Base - http://www.medicalnewsbase.com/

---

View Post: app pharmaceuticals receives approval for idarubicin hci injection
10 Aug 2009 by admin  
... kabi pharmaceuticals holding, inc. (nasdaq:apcvz ), announced today that it has received approval from the us food and drug administration (fda) … biopharmaceuticals, generics, fda app pharmaceuticals, idarubicin, idamycin, pfizer ...
View Blog: Medical Sales Jobs Websites - http://medical-sales-jobs-websites.com/

---

View Post: app pharmaceuticals receives approval for idarubicin hci injection
11 Aug 2009 by Amit  
aug 10, 2009 - app pharmaceuticals, inc., a wholly owned subsidiary of fresenius kabi pharmaceuticals holding, inc., announced today that it has received approval from the us fda to market idarubicin hydrochloride injection in three ...
View Blog: Generic Pharmaceuticals and Patents - http://genericspatent.blogspot.com/

---

View Post: twice daily fludarabine/ara-c associated to idarubicin, g-csf and ...
30 May 2009 by Marco Montillo, Francesca Ricci, Alessandra...  
in this study 52 patients with relapsed/refractory aml obtained a complete remission (cr) rate of 69.2% after flairg regimen (fludarabine and arabinosylcytosine twice daily, idarubicin, g-csf, atra). this schedule resulted effective and ...
View Blog: Leukemia Research - http://www.lrjournal.com/?rss=yes

---

View Post: How chemotherapy drugs block blood vessel growth
5 Nov 2009
The anthracycline class of chemotherapy – doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin – have been used for four decades to treat many cancers such as leukemia, lymphomas, sarcomas and carcinomas, the standard method ...
View Blog: Healthy Weightloss Programs - http://healthyweightlossprograms.net/

---